NEW YORK – A pair of new studies suggests that polygenic risk scores (PRS) for coronary artery disease (CAD) such as myocardial infarction might offer some predictive improvement when added to conventional clinical evaluation approaches, though genetic scores alone do not appear to have the predictive wherewithal to replace existing strategies.